Cargando…
Exploring the molecular mechanism of glycyrrhetinic acid in the treatment of gastric cancer based on network pharmacology and experimental validation
There is a wide range of pharmacological effects for glycyrrhetinic acid (GRA). Previous studies have shown that GRA could inhibit the proliferation of tumor cells, showing a promising value in the treatment of gastric cancer (GC). Nonetheless, the precise mechanism of the effect of GRA on GC remain...
Autores principales: | Li, Xia, Du, Yuhua, Huang, Shicong, Yang, Yi, Lu, Doudou, Zhang, Junfei, Chen, Yan, Zhang, Lei, Nan, Yi, Yuan, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449304/ https://www.ncbi.nlm.nih.gov/pubmed/37171392 http://dx.doi.org/10.18632/aging.204718 |
Ejemplares similares
-
Pharmacological Mechanisms and Adjuvant Properties of Licorice Glycyrrhiza in Treating Gastric Cancer
por: Tibenda, Joanna Japhet, et al.
Publicado: (2023) -
Investigation on the mechanism of Shaoyao-Gancao Decoction in the treatment of gastric carcinoma based on network pharmacology and experimental verification
por: Zhou, Xin, et al.
Publicado: (2023) -
18β-glycyrrhetinic acid inhibits proliferation of gastric cancer cells through regulating the miR-345-5p/TGM2 signaling pathway
por: Li, Xia, et al.
Publicado: (2023) -
18β-glycyrrhetinic acid regulates mitochondrial ribosomal protein L35-associated apoptosis signaling pathways to inhibit proliferation of gastric carcinoma cells
por: Yuan, Ling, et al.
Publicado: (2022) -
18β-glycyrrhetinic acid promotes gastric cancer cell autophagy and inhibits proliferation by regulating miR-328-3p/signal transducer and activator of transcription 3
por: Yang, Yi, et al.
Publicado: (2023)